Allurion initiates ENLIGHTEN trial for Elipse Balloon
BARIATRIC NEWS – Allurion Technologies has started the ENLIGHTEN clinical trial for the Elipse Balloon – the world’s first and only procedureless gastric balloon for weight loss. ENLIGHTEN is a randomised, sham-controlled study designed to evaluate the safety and efficacy of the Elipse Balloon in 400 individuals. The study will be conducted at up to 12 sites in the US.
Allurion Technologies Commences Landmark Pivotal U.S. Clinical Trial for the Elipse® Balloon
BUSINESSWIRE – First Patients Treated in the U.S. with the World’s First and Only Procedureless™ Gastric Balloon for Weight Loss
FierceMedTech’s 2017 Fierce 15
FIERCE MEDICAL DEVICES – When we were compiling this year’s crop of Fierce 15 companies, some clear themes stood out. Genomics. Bioelectronics. Artificial intelligence. But while multiple companies are working to improve the use of these technologies, there runs a deeper current: making care more accessible.
For example, Allurion Technologies is developing a weight-loss balloon that is swallowed in an outpatient procedure and is naturally passed from the body at the end of the treatment period.
Allurion Technologies Appoints Four Distinguished Board Members; Secures Term Loan from Silicon Valley Bank
BUSINESS WIRE – Allurion Technologies, maker of the Elipse® Balloon – the world’s first and only procedureless™ gastric balloon for weight loss – announces the appointment of Michael Davin, Gail Zauder, Todd Zavodnick and Krishna Gupta to its Board of Directors.
VIDEO – Allurion co-founder Shantanu Gaur on CNBC’s Mad Money
CNBC – Jim Cramer sat down with the founder of Allurion Technologies to hear about his privately-held biotech company’s revolutionary obesity treatment.
The Bloomberg Baystate Business Hour: Balloons and Robots
BLOOMBERG – Bloomberg Boston Bureau Chief Tom Moroney and Radio News Anchor Anne Mostue are joined by top names from local business and finance to medicine and politics, along with Bloomberg reporters covering the latest stories in and around Boston.
This Company Raised $27 Million for a Weight Loss Balloon You Can Swallow in a Pill
FORTUNE – Beyond diet and exercise, Americans who need to lose significant weight—whether to guard against diabetes, heart disease, or other obesity-related illnesses—don’t have a lot of ideal options. Bariatric surgery is invasive, risky, and expensive.
Allurion Raises $27 Million for Weight-Loss Tech
WSJ – Startup’s balloon-based system delivers weight loss without surgery
Swallowable gastric balloon could help the obese lose weight without surgery
THE GUARDIAN – Although not a replacement for bariatric surgery, temporary balloon could be used as early intervention or for those who do not want, or cannot have, surgery